— Know what they know.
Not Investment Advice

COGT NASDAQ

Cogent Biosciences, Inc.
1W: +2.5% 1M: +0.5% 3M: -19.1% YTD: -7.9% 1Y: +111.6% 3Y: +262.5% 5Y: +262.5%
$32.01
+1.10 (+3.56%)
 
Weekly Expected Move ±5.4%
$28 $30 $31 $33 $35
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 45 · $5.6B mcap · 156M float · 1.47% daily turnover · Short 57% of daily vol
Credit Risk of going bust: higher than 63% of companies Debt: 4.2% of company value Bonds: $38.2M held by 24 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.23 (down 99.3%), Cogent Biosciences, Inc. would be worth roughly what it owes.
Total debt $244.3M against a stock market value of $5.55B.
Distance to default 4.01 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $113.2M (short-term plus half of long-term), stock volatility 90.6%; Altman Z'' -0.72. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
32.7 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 1964.0%
Cost Advantage
33
Intangibles
25
Switching Cost
35
Network Effect
47
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. COGT has No discernible competitive edge (32.7/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. ROIC of 1964.0% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$52
Low
$54
Avg Target
$55
High
Based on 2 analysts since Aug 10, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$53.50
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-17 Piper Sandler — $52 $55 +3 +45.0% $37.93
2026-08-12 Guggenheim Michael Schmidt $20 $52 +32 +34.4% $38.70
2026-06-01 Stifel Nicolaus Laura Prendergast $40 $45 +5 +28.7% $34.96
2026-05-06 H.C. Wainwright Robert Burns $52 $55 +3 +48.7% $36.98
2026-02-19 Robert W. Baird — Initiated $35 — -8.6% $38.29
2026-02-18 Piper Sandler — Initiated $52 — +38.2% $37.62
2026-01-07 UBS Michael Yee Initiated $60 — +72.5% $34.78
2026-01-06 H.C. Wainwright — $14 $52 +38 +51.8% $34.26
2025-12-08 Jefferies — $20 $48 +28 +20.1% $39.97
2025-11-11 Raymond James Chris Raymond $30 $60 +30 +84.8% $32.46
2025-11-10 Stifel Nicolaus — $16 $40 +24 +14.4% $34.97
2025-11-10 Wedbush David Nierengarten Initiated $38 — +9.3% $34.76
2025-10-15 Stifel Nicolaus — Initiated $16 — -3.5% $16.58
2025-09-02 Raymond James — $22 $30 +8 +150.0% $12.00
2025-08-25 Guggenheim — Initiated $20 — +69.6% $11.79
2025-01-14 H.C. Wainwright Robert Burns $17 $14 -3 +69.7% $8.25
2024-09-24 Citigroup David Lebowitz $13 $15 +2 +40.8% $10.65
2024-09-03 Citigroup David Lebowitz Initiated $13 — +18.7% $10.95
2024-09-03 H.C. Wainwright Robert Burns Initiated $17 — +49.5% $11.37
2024-03-29 Jefferies Kelly Shi Initiated $20 — +197.6% $6.72
2022-12-14 Needham — Initiated $24 — +94.8% $12.32
2022-06-17 Raymond James Chris Raymond Initiated $22 — +139.4% $9.19
2022-06-10 Leerink Partners Christopher Liu Initiated $15 — +39.7% $10.74

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
Oct 27, 2026
DCF
2
ROE
1
ROA
1
D/E
2
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. COGT receives an overall rating of C-. Areas of concern: DCF (2/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-16 D+ C-
2026-10-12 C- D+
2026-07-30 C C-
2026-05-22 C- C
2026-05-21 C C-
2026-05-20 C- C
2026-04-01 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
0
Earnings Quality
45
Growth
—
Value
27
Momentum
—
Safety
100
Cash Flow
—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
10.41
Safe Zone
Piotroski F-Score
3/9
✗ ✗ ✓ ✓ ✗ ✓ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
-5.48
Bankruptcy prob: 0.4%
Low Risk
Credit Rating
BBB+
Score: 62.7/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.82x
Accruals: -12.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. COGT scores 10.41, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. COGT scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. COGT's implied 0.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. COGT receives an estimated rating of BBB+ (score: 62.7/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-13.86x
PEG
-1.53x
P/S
0.00x
P/B
10.28x
P/FCF
-21.40x
P/OCF
—
EV/EBITDA
-16.28x
EV/Revenue
—
EV/EBIT
-16.12x
EV/FCF
-19.63x
Earnings Yield
-5.70%
FCF Yield
-4.67%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. COGT currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.002
EBT / EBIT
×
EBIT Margin
—
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.614
Assets / Equity
=
ROE
-109.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. COGT's ROE of -109.7% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$32.01
Median 1Y
$22.38
5th Pctile
$4.15
95th Pctile
$120.80
Ann. Volatility
105.8%
Analyst Target
$53.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Andrew Robbins
Chief Executive Officer
$724,554 $12,993,250 $27,762,684
Jessica Sachs Medical
edical Officer
$549,389 $4,535,250 $9,178,177
John Robinson Scientific
ntific Officer
$532,035 $4,535,250 $9,150,297
Cole Pinnow Commercial
ercial Officer
$482,266 $4,535,250 $8,839,548
John Green Financial
ancial Officer
$510,677 $3,965,750 $8,546,329

CEO Pay Ratio

113:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $27,762,684
Avg Employee Cost (SGA/emp): $246,446
Employees: 258

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
258
+25.9% YoY
Revenue / Employee
—
Profit / Employee
$-1,274,950
NI: $-328,937,000
SGA / Employee
$246,446
Avg labor cost proxy
R&D / Employee
$1,045,659
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -37.5% -32.2% -44.0% -41.2% -51.5% -59.7% -72.0% -47.1% -59.9% -74.9% -65.7% -62.9% -78.5% -99.5% -84.0% -1.1% -95.4% -73.7% -85.7% -1.1% -1.10%
ROA -33.0% -29.9% -41.0% -36.9% -45.9% -52.6% -63.1% -41.5% -51.7% -62.6% -57.4% -55.2% -65.5% -79.8% -70.9% -80.6% -72.7% -52.0% -59.7% -68.0% -68.00%
ROIC 24.7% 25.5% -220.1% -4.1% -4.9% -7.3% -5.5% -3.5% -3.6% -15.0% -35.1% -6.9% 67.9% 16.4% 23.8% 10.7% 8.7% 23.4% 14.3% 19.6% 19.64%
ROCE -30.9% -35.1% -49.8% -33.3% -42.1% -54.0% -66.0% -46.6% -60.4% -75.6% -51.7% -61.3% -77.0% -99.4% -1.2% -1.4% -82.9% -38.2% -42.0% -48.6% -48.57%
Gross Margin — — — — — — — — — — — — — — — — — — — — —
Operating Margin — — — — — — — — — — — — — — — — — — — — —
Net Margin — — — — — — — — — — — — — — — — — — — — —
EBITDA Margin — — — — — — — — — — — — — — — — — — — — —
FCF Margin — — — — — — — — — — — — — — — — — — — — —
OCF Margin — — — — — — — — — — — — — — — — — — — — —
ROE 3Y Avg snapshot only -1.05%
ROE 5Y Avg snapshot only -78.87%
ROA 3Y Avg snapshot only -67.12%
ROIC Economic snapshot only -39.58%
Cash ROA snapshot only -36.85%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -5.71 -5.20 -3.71 -4.07 -8.27 -5.81 -5.15 -5.63 -4.73 -2.65 -3.00 -3.68 -4.91 -3.37 -2.52 -2.89 -5.58 -7.30 -18.55 -17.55 -13.857
P/S Ratio — — — — — — — — — — — — — — — — — — — — 0.000
P/B Ratio 1.70 1.75 1.80 1.39 3.58 3.19 3.41 2.54 2.77 1.98 1.51 2.24 3.78 3.36 3.10 5.30 5.43 3.77 10.82 12.43 10.282
P/FCF -6.89 -6.21 -4.34 -4.80 -9.00 -6.49 -5.56 -6.19 -5.86 -3.26 -3.78 -4.70 -6.19 -4.14 -3.05 -3.50 -6.66 -9.03 -22.96 -21.40 -21.401
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -2.27 -2.15 -1.63 -1.33 -6.17 -4.05 -3.66 -3.50 -3.06 -1.29 -0.98 -2.09 -3.48 -2.22 -1.62 -2.20 -4.42 -5.33 -16.96 -16.28 -16.279
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT -2.22 -2.11 -1.60 -1.31 -5.93 -3.89 -3.52 -3.37 -3.00 -1.26 -0.97 -2.06 -3.42 -2.19 -1.59 -2.17 -4.36 -5.26 -16.77 -16.12 -16.120
EV/FCF -2.79 -2.63 -1.93 -1.59 -6.67 -4.58 -4.09 -4.02 -4.05 -1.68 -1.31 -2.76 -4.54 -2.84 -2.02 -2.75 -5.32 -6.59 -20.77 -19.63 -19.628
Earnings Yield -17.5% -19.2% -27.0% -24.6% -12.1% -17.2% -19.4% -17.8% -21.1% -37.7% -33.3% -27.1% -20.4% -29.7% -39.7% -34.6% -17.9% -13.7% -5.4% -5.7% -5.70%
FCF Yield -14.5% -16.1% -23.1% -20.8% -11.1% -15.4% -18.0% -16.2% -17.1% -30.7% -26.4% -21.3% -16.1% -24.2% -32.8% -28.6% -15.0% -11.1% -4.4% -4.7% -4.67%
Price/Tangible Book snapshot only 12.431
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 12.42 13.04 10.89 11.96 12.59 9.87 10.71 12.99 8.24 7.09 12.05 9.25 6.44 5.32 5.13 4.19 6.38 14.23 15.14 13.57 13.573
Quick Ratio 12.42 13.04 10.89 11.96 12.59 9.87 10.71 12.99 8.24 7.09 12.05 9.25 6.44 5.32 5.13 4.19 6.38 14.23 15.14 13.57 13.573
Debt/Equity 0.02 0.01 0.02 0.09 0.07 0.08 0.09 0.06 0.06 0.07 0.04 0.05 0.06 0.07 0.08 0.39 0.20 0.40 0.39 0.46 0.459
Net Debt/Equity -1.01 -1.01 -1.00 -0.93 -0.93 -0.94 -0.90 -0.89 -0.86 -0.96 -0.99 -0.92 -1.01 -1.05 -1.04 -1.14 -1.09 -1.02 -1.03 -1.03 -1.029
Debt/Assets 0.02 0.01 0.02 0.08 0.06 0.07 0.07 0.05 0.05 0.06 0.04 0.04 0.05 0.05 0.06 0.22 0.14 0.27 0.26 0.29 0.293
Debt/EBITDA -0.06 -0.04 -0.04 -0.25 -0.16 -0.14 -0.13 -0.12 -0.10 -0.09 -0.08 -0.08 -0.07 -0.07 -0.06 -0.21 -0.20 -0.77 -0.68 -0.66 -0.655
Net Debt/EBITDA 3.33 2.92 2.04 2.68 2.16 1.69 1.31 1.89 1.37 1.21 1.87 1.47 1.27 1.01 0.82 0.61 1.11 1.97 1.79 1.47 1.470
Interest Coverage — — — — — — — — — — — — — — — -946.80 -169.97 -108.87 -82.94 -72.72 -72.720
Equity Multiplier 1.09 1.08 1.10 1.15 1.14 1.18 1.18 1.13 1.17 1.22 1.13 1.15 1.22 1.28 1.30 1.77 1.41 1.47 1.49 1.57 1.568
Cash Ratio snapshot only 13.362
Debt Service Coverage snapshot only -72.009
Cash to Debt snapshot only 3.244
FCF to Debt snapshot only -1.266
Defensive Interval snapshot only 747.7 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover — — — — — — — — — — — — — — — — — — — — —
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.07 0.22 0.25 0.19 0.193
DSO — — — — — — — — — — — — — — — — — — — — —
DIO — — — — — — — — — — — — — — — 0 0 0 0 0 0.0 days
DPO — — — — — — — — — — — — — — — 4038 4904 1682 1459 1887 1887.1 days
Cash Conversion Cycle — — — — — — — — — — — — — — — — — — — — —
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -1.0% -1.0% -1.0% -1.0% — — — — — — — — — — — — — — — — —
Net Income 4.0% 3.4% -13.3% -22.3% -1.1% -94.0% -62.5% -43.6% -41.5% -37.2% -43.2% -44.3% -36.4% -33.0% -27.0% -25.1% -21.5% -28.6% -31.5% -32.8% -32.77%
EPS 76.3% 76.9% 12.4% 4.8% -22.5% -20.6% -3.6% 5.1% -14.3% -11.5% -6.8% -8.7% -6.7% -4.4% -6.3% -8.5% -16.9% -1.1% 12.8% 11.1% 11.12%
FCF -39.2% -68.7% -98.1% -1.1% -1.4% -1.1% -76.3% -54.1% -24.3% -24.6% -22.6% -24.4% -33.9% -33.2% -32.3% -31.9% -28.4% -27.7% -28.5% -31.8% -31.79%
EBITDA -1.9% -1.1% -1.2% -1.2% -1.1% -91.7% -66.8% -48.1% -52.3% -44.1% -45.4% -43.3% -32.1% -30.1% -24.7% -24.4% -18.5% -23.7% -25.8% -27.3% -27.35%
Op. Income 10.4% 8.1% -6.0% -14.2% -1.1% -95.7% -69.5% -51.6% -49.3% -40.8% -42.4% -43.1% -34.5% -32.6% -26.9% -22.5% -18.1% -20.8% -25.5% -29.8% -29.84%
OCF Growth snapshot only -31.65%
Asset Growth snapshot only 2.04%
Equity Growth snapshot only 2.43%
Debt Growth snapshot only 3.03%
Shares Change snapshot only 49.39%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — — — — — — — — — — —
Revenue 5Y — — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 31.5% 39.3% 36.5% 74.1% 78.9% 82.6% 89.1% 1.3% 36.5% 7.7% 26.1% 23.5% 21.3% 12.2% 11.1% -9.1% 8.7% 46.1% 50.8% 28.6% 28.60%
Assets 5Y — — — — — — 43.4% 30.7% 30.3% 29.5% 42.4% 44.1% 46.0% 46.0% 48.8% 54.7% 24.9% 30.2% 30.6% 29.6% 29.57%
Equity 3Y 42.9% 52.6% 56.2% 1.0% 1.2% 1.0% 1.1% 1.6% 37.7% 3.2% 23.0% 20.6% 16.8% 6.2% 5.2% -21.4% 1.4% 35.5% 39.6% 15.2% 15.18%
Book Value 3Y -18.2% -15.4% -14.0% 7.4% 3.7% -4.3% -2.5% 23.5% -33.2% -49.0% -11.8% -12.1% -16.7% -22.0% -22.6% -40.6% -14.1% 37.4% 4.0% -12.6% -12.59%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.01 0.37 0.36 0.46 0.43 0.84 0.09 0.14 0.21 0.80 0.72 0.68 0.66 0.66 0.66 0.66 0.66 0.66 0.66 0.66 0.662
Earnings Stability 0.85 0.75 0.85 0.81 0.81 0.83 0.90 0.88 0.86 0.88 0.90 0.91 0.91 0.95 0.97 0.98 0.96 0.96 0.97 0.97 0.965
Margin Stability 0.00 0.00 0.00 0.00 — — 0.00 0.00 — — — — — — — — — — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.98 0.99 0.95 0.91 0.50 0.50 0.50 0.83 0.83 0.85 0.83 0.82 0.85 0.87 0.89 0.90 0.91 0.89 0.87 0.87 0.869
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 0.71 0.32 0.20 0.47 -0.02 -0.22 -0.24 -0.07 -0.22 -0.30 0.07 -0.21 -0.26 -0.35 -0.65 -1.30 -0.29 0.36 0.28 0.51 0.512
Gross Margin Trend — — — — — — — — — — — — — — — — — — — — —
FCF Margin Trend — — — — — — — — — — — — — — — — — — — — —
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.81 0.81 0.83 0.82 0.88 0.85 0.88 0.86 0.78 0.80 0.79 0.78 0.79 0.81 0.82 0.82 0.84 0.80 0.80 0.82 0.815
FCF/OCF 1.03 1.03 1.03 1.04 1.05 1.06 1.06 1.06 1.03 1.02 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.006
FCF/Net Income snapshot only 0.820
CapEx/Revenue — — — — — — — — — — — — — — — — — — — — —
CapEx/Depreciation snapshot only 0.461
Accruals Ratio -0.06 -0.06 -0.07 -0.07 -0.06 -0.08 -0.08 -0.06 -0.11 -0.13 -0.12 -0.12 -0.14 -0.15 -0.13 -0.14 -0.12 -0.10 -0.12 -0.13 -0.126
Sloan Accruals snapshot only 1.001
Cash Flow Adequacy snapshot only -181.442
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -36.4% -10.1% -11.3% -45.0% -19.3% -19.9% -21.3% -18.4% -19.4% -31.8% -58.9% -25.5% -18.0% -24.8% -3.6% -3.0% -14.7% -29.6% -11.3% -11.2% -11.22%
Total Shareholder Return -36.4% -10.1% -11.3% -45.0% -19.3% -19.9% -21.3% -18.4% -19.4% -31.8% -58.9% -25.5% -18.0% -24.8% -3.6% -3.0% -14.7% -29.6% -11.3% -11.2% -11.22%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.96 0.96 0.97 0.97 0.97 0.95 0.93 0.92 0.92 0.92 0.93 0.95 0.95 0.95 0.95 0.96 0.98 0.99 1.00 1.00 1.002
EBIT Margin — — — — — — — — — — — — — — — — — — — — —
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.13 1.08 1.07 1.12 1.12 1.13 1.14 1.14 1.16 1.20 1.14 1.14 1.20 1.25 1.18 1.33 1.31 1.42 1.44 1.61 1.614
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.47 $-1.65 $-2.02 $-2.22 $-1.80 $-1.99 $-2.10 $-2.10 $-2.06 $-2.22 $-2.24 $-2.29 $-2.20 $-2.32 $-2.38 $-2.48 $-2.57 $-4.87 $-2.07 $-2.21 $-2.21
Book Value/Share $4.95 $4.89 $4.16 $6.47 $4.17 $3.63 $3.16 $4.66 $3.52 $2.97 $4.45 $3.76 $2.86 $2.32 $1.93 $1.35 $2.64 $9.41 $3.56 $3.11 $3.11
Tangible Book/Share $4.95 $4.89 $4.16 $6.47 $4.17 $3.63 $3.16 $4.66 $3.52 $2.97 $4.45 $3.76 $2.86 $2.32 $1.93 $1.35 $2.64 $9.41 $3.56 $3.11 $3.11
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-1.22 $-1.38 $-1.73 $-1.88 $-1.66 $-1.78 $-1.94 $-1.91 $-1.66 $-1.80 $-1.78 $-1.79 $-1.74 $-1.89 $-1.97 $-2.05 $-2.16 $-3.93 $-1.68 $-1.81 $-1.81
OCF/Share $-1.19 $-1.34 $-1.68 $-1.82 $-1.58 $-1.68 $-1.84 $-1.81 $-1.61 $-1.77 $-1.76 $-1.79 $-1.74 $-1.88 $-1.96 $-2.04 $-2.15 $-3.91 $-1.67 $-1.80 $-1.80
Cash/Share $5.09 $5.01 $4.24 $6.59 $4.16 $3.68 $3.11 $4.41 $3.24 $3.06 $4.60 $3.66 $3.05 $2.60 $2.17 $2.08 $3.41 $13.32 $5.07 $4.63 $4.63
EBITDA/Share $-1.50 $-1.69 $-2.04 $-2.25 $-1.79 $-2.01 $-2.17 $-2.20 $-2.20 $-2.36 $-2.36 $-2.37 $-2.28 $-2.41 $-2.46 $-2.56 $-2.60 $-4.87 $-2.05 $-2.18 $-2.18
Debt/Share $0.09 $0.07 $0.08 $0.57 $0.29 $0.28 $0.28 $0.26 $0.22 $0.22 $0.20 $0.18 $0.16 $0.16 $0.15 $0.53 $0.53 $3.74 $1.40 $1.43 $1.43
Net Debt/Share $-5.00 $-4.94 $-4.16 $-6.02 $-3.87 $-3.40 $-2.84 $-4.15 $-3.02 $-2.85 $-4.40 $-3.48 $-2.88 $-2.44 $-2.02 $-1.55 $-2.89 $-9.58 $-3.68 $-3.20 $-3.20
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 10.406
Altman Z-Prime snapshot only 20.426
Piotroski F-Score 4 2 2 2 2 1 1 3 2 2 3 2 2 2 1 1 1 4 3 3 3
Beneish M-Score — — — — — — — — — — — — — — — — — — — — —
Ohlson O-Score snapshot only -5.477
ROIC (Greenblatt) snapshot only -48.72%
Net-Net WC snapshot only $2.94
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB+
Credit Score 72.96 74.15 74.72 75.72 75.62 76.84 76.00 75.96 76.21 54.28 76.21 76.30 76.10 53.45 44.04 31.58 57.29 52.95 63.00 62.72 62.719
Credit Grade snapshot only 8
Credit Trend snapshot only 31.135
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 58
Sector Credit Rank snapshot only 54

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms